CWP-291 (JW Pharmaceutical)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCWP-291 (JW Pharmaceutical)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action78 kDa glucose-regulated protein inhibitorsCoronavirus spike glycoprotein inhibitors
Targets78 kDa glucose-regulated proteinCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Lung Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJw Pharmaceutical Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJw Pharmaceutical Corp
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Lung Diseases

Other Information

ATC CodeN/A
Related LinksN/A